| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/17/2007 | US7244711 Mixtures of enzyme inhibitors and free radical scavengers selected from phenolic compounds, phenothiazines and diphenylamines, used for prophylaxis of rheumatic diseases, pancreatitis, multiple sclerosis or gastrointestinal disorders |
| 07/17/2007 | US7244708 Inhibitors of memapsin 2 and use thereof |
| 07/17/2007 | US7244429 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 07/17/2007 | US7244412 Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia |
| 07/17/2007 | CA2494338C Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients |
| 07/17/2007 | CA2389235C Controlled release hydrocodone formulations |
| 07/17/2007 | CA2240060C O-carbamoyl-phenylalaninol compounds, their pharmaceutically useful salts and process for preparing the same |
| 07/17/2007 | CA2231436C Neural transplantation using pluripotent neuroepithelial cells |
| 07/17/2007 | CA2145535C Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system, particularly in brain |
| 07/17/2007 | CA2132887C Tricyclic 1-aminoethylpyrrole-derivatives |
| 07/12/2007 | WO2007079406A1 Small molecule inhibitors of pdz interactions |
| 07/12/2007 | WO2007079141A2 Method of identifying compounds useful to treat neuronal degenerative diseases |
| 07/12/2007 | WO2007078251A1 Compounds |
| 07/12/2007 | WO2007077949A1 Heterocyclic janus kinase 3 inhibitors |
| 07/12/2007 | WO2007077490A2 Bicyclic heteroaryl compounds as pde10 inhibitors |
| 07/12/2007 | WO2007077469A1 Optical isomers of dihydro-2,3-benzodiazepines and their stereoselective synthesis |
| 07/12/2007 | WO2007077159A1 Imidazo (1,2-a)pyridin-3-yl-acetic acid hydrazides, processes for their preparation and pharmaceutical uses thereof |
| 07/12/2007 | WO2007077004A1 Macrocyclic compounds useful as bace inhibitors |
| 07/12/2007 | WO2007076709A1 Tri-substituted 1h-imidazolyl compounds, preparation methods, pharmaceutical compositions and pharmaceutical uses thereof |
| 07/12/2007 | WO2007052123A3 Pyrazine derivatives as sodium channel modulators for the treatment of pain |
| 07/12/2007 | WO2007034279A3 C3a antagonists and pharmaceutical compositions thereof |
| 07/12/2007 | WO2007031828A3 Therapeutic pyrrolidines |
| 07/12/2007 | WO2007029063A3 Treatment and/or prevention of pervasive developmental disorders |
| 07/12/2007 | WO2007023395A3 Benzo[b]furane and benzo[b]thiophene derivatives |
| 07/12/2007 | WO2007019078A3 Tricyclic beta-secretase inhibitors for the treatment of alzheimer's disease |
| 07/12/2007 | WO2007017240A3 Composition of n-3 fatty acids having high concentration of epa and/or dha and containing n-6 fatty acids |
| 07/12/2007 | WO2007016501A3 Compositions and method for brain specific targeted delivery of therapeutic agents |
| 07/12/2007 | WO2006123244A3 Carbamate derivatives as positive allosteric modulators of metabotropic glutamate receptors |
| 07/12/2007 | WO2006103537A3 Treatment of epilepsy with non-imidazole alkylamines histamine h3-receptor ligands |
| 07/12/2007 | WO2006098834A9 Crystalline forms of ziprasidone mesylate |
| 07/12/2007 | WO2006096529A3 Genes involved in neurodegenerative conditions |
| 07/12/2007 | US20070161707 Pharmaceutical uses for alpha2delta ligands |
| 07/12/2007 | US20070161706 Pharmaceutical uses for alpha2delta ligands |
| 07/12/2007 | US20070161692 Conformationally restricted polyamine analogs as disease therapies |
| 07/12/2007 | US20070161681 Ether derivatives useful as inhibitors of pde4 isozymes |
| 07/12/2007 | US20070161666 Pyrrolo[2,3-d]pyrimidine compounds |
| 07/12/2007 | US20070161662 6-Arylmethyl-substituted pyrazolopyrimidines |
| 07/12/2007 | US20070161647 QUINOLINE-4-CARBOXAMIDE DERIVATIVES AS NK-3 and NK-2 RECEPTOR ANTAGONISTS |
| 07/12/2007 | US20070161646 Piperidine Derivatives and Their Use as Modulators of Chemokine Receptor Activity (Especially CCR5) |
| 07/12/2007 | US20070161641 2-(4-thieno[2,3-d]isoxazol-3-yl-piperidin-1-ylmethyl)-(2R,3R)-cyclopropanecarboxylic acid (trans4-methyl-cyclohexyl)-amide; psychological disorders, neurodegenerative diseases, antidepressant; drug abuse, sleep disorders |
| 07/12/2007 | US20070161640 Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders |
| 07/12/2007 | US20070161631 Substituted Phenoxyacetic Acids |
| 07/12/2007 | US20070161628 Phosphodiesterase inhibitors |
| 07/12/2007 | US20070161621 Spiroazacyclic compounds as monoamine receptor modulators |
| 07/12/2007 | US20070161620 Isoquinoline compound and pharmaceutical use thereof |
| 07/12/2007 | US20070161614 Pyridylether derivatives, their preparation and use |
| 07/12/2007 | US20070161610 Bipolar trans carotenoid salts and their uses |
| 07/12/2007 | US20070161607 immunosuppressive treatment of autoimmune disorders or inflammatory diseases; [Tris-(4-fluoro-phenyl)-methyl]-phosphonic acid dimethyl ester; Gardos channel antagonists |
| 07/12/2007 | US20070161597 A time-release formulation of a water-soluble derivative having the fatty acid moiety removed and an antiinflammatory agent; opoid resistant neuropathic pain, amputation pain or neuralgia; |
| 07/12/2007 | US20070161549 Glycosylation-deficient hepatocyte growth factor |
| 07/12/2007 | US20070161046 Truncated aggrecanase molecules |
| 07/12/2007 | US20070160668 Prolonged release bioadhesive therapeutic systems |
| 07/12/2007 | US20070160603 Antibodies Against Tumor Necrosis Factor Delta (APRIL) |
| 07/12/2007 | US20070160594 Method of Diagnosing and Treating Cartilaginous Disorders |
| 07/12/2007 | US20070160593 Sugar chain-cleaving agent |
| 07/12/2007 | US20070160585 Remedy for prion disease and method of producing the same |
| 07/12/2007 | US20070160537 In vivo screening method of therapeutic agent for memory/learning dysfunctions by schizophrenia |
| 07/12/2007 | DE60125335T2 Azacyclische verbindungen zur verwendung in der behandlung von mit serotonin verwandten krankheiten Azacyclic compounds for use in the treatment of serotonin-related diseases |
| 07/12/2007 | DE102005054610A1 Flupirtin enthaltende Arzneimittelzubereitung mit kontrollierter Wirkstofffreisetzung Flupirtine-containing pharmaceutical composition with controlled drug release |
| 07/12/2007 | DE10161251B4 Schlafmittel mit Xenon Sleeping pills with xenon |
| 07/12/2007 | CA2641421A1 Small molecule inhibitors of pdz interactions |
| 07/12/2007 | CA2636264A1 Bicyclic heteroaryl compounds as pde10 inhibitors |
| 07/12/2007 | CA2635850A1 Heterocyclic janus kinase 3 inhibitors |
| 07/12/2007 | CA2635802A1 Imidazo (1,2-a)pyridin-3-yl-acetic acid hydrazides, processes for their preparation and pharmaceutical uses thereof |
| 07/12/2007 | CA2635466A1 Gastric retentive gabapentin dosage forms and methods for using same |
| 07/12/2007 | CA2634983A1 Macrocyclic compounds useful as bace inhibitors |
| 07/12/2007 | CA2634037A1 2-amino-5-piperidinylimidazolone compounds and use thereof for .beta.-secretase modulation |
| 07/12/2007 | CA2633804A1 Optical isomers of dihydro-2,3-benzodiazepines and their stereoselective synthesis |
| 07/11/2007 | EP1806141A1 Par-2 antagonists |
| 07/11/2007 | EP1806140A1 Therapeutic or preventive agent for diabetic neuropathy |
| 07/11/2007 | EP1806133A1 Method for modifying the ambience, and spray liquid and sprayer used in the method |
| 07/11/2007 | EP1805510A1 Therapeutic strategy for treating autoimmune and degenerative diseases |
| 07/11/2007 | EP1805222A1 Antibodies directed to the mammalian eag1 ion channel protein |
| 07/11/2007 | EP1805183A1 Novel diazabicyclic aryl derivatives and their medical use |
| 07/11/2007 | EP1805169A1 Histamine h3 receptor inhibitors, their preparation and therapeutic uses |
| 07/11/2007 | EP1805165A1 1-(hetero)aryl-3-amino-pyrollidine derivatives for use as mglur3 receptor antagonists |
| 07/11/2007 | EP1805164A2 6-(pyridinyl)-4-pyrimidone derivates as tau protein kinase 1 inhibitors |
| 07/11/2007 | EP1805141A1 Piperidines and related compounds for treatment of alzheimer's disease |
| 07/11/2007 | EP1805134A2 4-aminotetracyclines and methods of use thereof |
| 07/11/2007 | EP1805129A1 (biphenyl) carboxylic acids and derivatives thereof |
| 07/11/2007 | EP1804919A2 Cgrp receptor antagonists |
| 07/11/2007 | EP1804838A2 Drug conjugates of long chain fatty acid or ester moieties as protein binding prodrugs |
| 07/11/2007 | EP1804804A2 Loxapine analogs and methods of use thereof |
| 07/11/2007 | EP1804800A1 Use of 4-(4-methylpiperazin-1-ylmethyl)-n-ý4-methyl-3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl¨-benzamide to inhibit the tyrosine kinase receptor c-fms |
| 07/11/2007 | EP1804798A2 Methods for the treatment of substance abuse and addiction |
| 07/11/2007 | EP1804796A2 Amino substituted aryloxybenzylpiperidine derivatives |
| 07/11/2007 | EP1592428B1 New crystalline modification of 2-(3,5-bis-trifluoromethyl-phenyl)-n- 6-(1,1-dioxo-1lamda-6 -thiomorpholin-4-yl)-4(4-fluoro-2-methyl-phenyl)-pyridin-3-yl -n-methyl-isobutyramide |
| 07/11/2007 | EP1551395B1 5-ht 1b/1d receptor agonists for the treatment of headache resulting from administering an endothelin receptor antagonist |
| 07/11/2007 | EP1535065A4 Neuroprotective synergy of erythropoietin and insulin-like growth factor |
| 07/11/2007 | EP1458706B1 Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 07/11/2007 | EP1289535B1 Apoptotic entities for use in treatment of neurodegenerative and other neurological disorders |
| 07/11/2007 | EP1204414B1 Use of morphinan derivates as medicines |
| 07/11/2007 | EP1177445B1 Methods for screening gaba-modulatory compounds for specified pharmacological activities |
| 07/11/2007 | EP1140907B1 Triazole compounds with dopamine-d3-receptor affinity |
| 07/11/2007 | EP1028945B1 Substituted pyridine compounds as anti-inflammatory agents |
| 07/11/2007 | CN1997646A Diphenylimidazopyrimidine and -imidazole amines as inhibitors of beta-secretase |
| 07/11/2007 | CN1997635A Dihydrobenzofuranyl alkanamine derivatives as 5HT2C agonists |
| 07/11/2007 | CN1997631A New disubstituted phenylpiperidines as modulators of dopamine and serotonin neurotransmission |
| 07/11/2007 | CN1997630A New disubstituted phenylpiperidines as modulators of dopamine neurotransmission |
| 07/11/2007 | CN1997400A Conjugated psychotropic drugs and uses thereof |